MedTrace Logo

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

NCT06987708 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2026-03-23

No results posted yet for this study

Summary

A prospective, pilot study to assess the impact of a 12-month multi-focal lifestyle intervention on myeloma-relevant biomarkers in patients with MGUS or SM. The multimodal lifestyle intervention has six foci that patients will participate in over the course of one-year.

Conditions

  • Monoclonal Gammopathy of Uncertain Significance
  • Smoldering Myeloma

Interventions

OTHER

The Multimodal Lifestyle Intervention

The multimodal lifestyle intervention has six foci: positive cognition, exercise/movement, stress reduction, social connection, emotional well-being, and nutrition

Sponsors & Collaborators

  • Center for Cancer Lifestyle Management

    collaborator UNKNOWN

  • Hackensack Meridian Health

    lead OTHER

Principal Investigators

  • David Siegel, MD · Hackensack Meridian Health

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2028-05-01
Completion
2028-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06987708 on ClinicalTrials.gov